Search

everythinglearnresearchcommunity

for

Search:↓

Severe sarcoidosis often requires long-term systemic corticosteroids and multidisciplinary care, with most patients improving but some experiencing persistent symptoms or complications.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Blood tests confirmed a baby in the womb had a CMV infection.

Carbamazepine caused hair loss and skin eruptions in a woman, which improved after stopping the medication.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

The virus was not found in the semen and urine of a man who tested positive for COVID-19.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Finasteride may cause slight depression and anxiety.

Minoxidil effectively treats severe hypertension but may cause side effects, so careful monitoring is needed.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Human hair follicles can make and process prostaglandins, which may affect hair growth.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Minoxidil controls blood pressure effectively, but may cause side effects like hypertrichosis.

Captopril reduces heart mass, while minoxidil has opposite effects and side effects.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

These drugs raise prostaglandin-like material in dog blood, possibly causing blood vessel widening.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.